Wells Fargo’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,428
Closed -$489K 7218
2021
Q4
$489K Hold
9,428
﹤0.01% 4681
2021
Q3
$563K Hold
9,428
﹤0.01% 4600
2021
Q2
$585K Buy
+9,428
New +$628K ﹤0.01% 4539
2020
Q3
Sell
-23,883
Closed -$2K 6434
2020
Q2
$2K Buy
+23,883
New +$1.29M ﹤0.01% 6093

Other funds holding EHC

Wells Fargo's EHC Position: Q1 2026 in Review

Wells Fargo increased its Encompass Health (EHC) stake by 7.6% in Q1 2026, buying an estimated $1.25M and bringing the position to 173,413 shares worth $16.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

Wells Fargo first reported a position in EHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $141M in Q3 2018. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Wells Fargo held 173,413 shares of Encompass Health worth $16.8M as of Q1 2026.
  • Wells Fargo bought 12,221 Encompass Health shares in Q1 2026, an estimated $1.25M.
  • Encompass Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1641 holding.
  • Wells Fargo first reported a position in Encompass Health in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Encompass Health position peaked at $141M in Q3 2018.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.